Arrhythmogenic right ventricular cardiomyopathy is a life threatening genetic heart condition that causes problems with the muscle tissue around your heart’s right ventricle. Arrhythmogenic right ...

Ultrasound echocardiogram of a patient taking a test for heart diseases. Echocardiogram monitor with an image of patient’s heart. Medical ultrasound scan. Clinicians should have a high index of ...

A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which ...

The FDA has awarded orphan drug designation to Tenaya Therapeutics Inc.'s gene therapy product candidate, TN-401, for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC). TN-401 is ...

"This study showed that RV function, including RV strain, decreases over time despite preserved LV ejection fraction, and is associated with poor cardiovascular outcomes. RV function may be more ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information by sharing relevant background and reasoning ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

The cricket world is in shock following the news that James Taylor, the 26-year-old England batsman, has been forced to retire with a serious heart condition. Here is an outline of the condition ...

The true prevalence of ARVD/C is still to be determined, but it is likely to be an under recognized condition. In Italy, the prevalence has been reported as 1:5000 people, accounting for 20 percent of ...